Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127764182 | 12776418 | 2 | F | 20160205 | 20160927 | 20160923 | 20160929 | EXP | AU-ABBVIE-16P-008-1734292-00 | ABBVIE | 29.00 | YR | F | Y | 0.00000 | 20160929 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127764182 | 12776418 | 1 | PS | LOPINAVIR/RITONAVIR | LOPINAVIRRITONAVIR | 1 | Oral | D | UNKNOWN | 21226 | 1 | DF | QID | ||||||
| 127764182 | 12776418 | 2 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | D | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127764182 | 12776418 | 1 | HIV infection |
| 127764182 | 12776418 | 2 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127764182 | 12776418 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127764182 | 12776418 | Abortion spontaneous | |
| 127764182 | 12776418 | Foetal death | |
| 127764182 | 12776418 | Maternal exposure during pregnancy | |
| 127764182 | 12776418 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |